Presenter(s)
T. Slater1, T. Arsenault2, K. O'Carroll2, S. K. Attia2, Y. Sun1, H. Newton3, C. Badve4, D. E. Spratt5, H. K. Perlow2, P. Vempati2, and A. Baydoun2; 1Case Western Reserve University School of Medicine, Cleveland, OH, 2Department of Radiation Oncology, University Hospitals Cleveland Medical Center/ Seidman Cancer Center, Cleveland, OH, 3Division of Neuro-Oncology, University Hospitals Cleveland Medical Center/ Seidman Cancer Center, Cleveland, OH, 4Department of Radiology, University Hospitals Cleveland Medical Center, Cleveland, OH, 5University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH
Purpose/Objective(s):
DOTATATE positron emission tomography (PET) has demonstrable clinical utility for intracranial meningioma, but adoption has been limited by infrastructure requirements and related costs. Artificial intelligence (AI)-based image-to-image translation could potentially address these limitations if comparable imaging information could be derived from magnetic resonance imaging (MRI). Here, we report a deep learning model that generates synthetic DOTATATE PET images from T1- and T2-weighted brain MRI.Materials/Methods:
Patients enrolled in a single-institution meningioma registry were included between 2021 and 2025. A conditional generative adversarial network was trained and evaluated using patient-level 10-fold cross validation. Input images were T1 post-contrast and T2 FLAIR MRI sequences. All images were resampled to a 1 mm isotropic resolution, co-registered, and padded or cropped to 256×256 pixels in the axial plane. A 2.5D approach was employed, incorporating adjacent slices to provide through-plane spatial context. In the evaluation phase, images were generated for the whole brain, and performance was quantified by comparing the synthetic and ground-truth PET images using mean absolute error (MAE), root mean squared error (RMSE), maximum standardized uptake value (SUV) error, and mean SUV error. Radiologist interpretation-derived tumor masks were used to compute tumor-specific metrics. Image quality was quantified using the structural similarity index (SSIM) and peak signal-to-noise ratio (PSNR).Results:
The dataset consisted of 40 patients (mean age 56.6 ± 18.5 [SD]; 9 males; 31 females) with 43 independent MRI-PET pairs due to repeated scans. Thirty patients underwent resection, with pathology demonstrating 8 WHO Grade I, 18 WHO Grade II, and 2 WHO Grade III lesions (2 patients had unknown WHO Grade). Average model performance metrics are summarized in Table 1. An MAE of 0.18 ± 0.08 SUV ([g/mL]) was achieved over the whole image, compared with 3.2 ± 2.1 SUV ([g/mL]) over the tumor area.Conclusion:
To our knowledge, this is the first reported model demonstrating the feasibility of AI-based generation of synthetic DOTATATE PET images from routine brain MRI. Future work includes refinement and external validation with multi-institutional data. If robustly validated, our AI-based synthetic DOTATATE PET could have global applications in the management of meningiomas. Table 1: Quantitative Performance Metrics for Synthetic versus Reference DOTATATE PET Images| Domain | Metric | Value (Mean ± SD) |
| Whole Image | MAE (SUV [g/mL]) | 0.18 ± 0.08 |
| RMSE (SUV [g/mL]) | 0.54 ± 0.20 | |
| Percent Bias (%) | 28 ± 47 | |
| SSIM (unitless) | 0.89 ± 0.04 | |
| PSNR (dB) | 34.8 ± 4.6 | |
| Tumor Only | MAE (SUV [g/mL]) | 3.2 ± 2.1 |
| RMSE (SUV [g/mL]) | 4.1 ± 3.0 | |
| Percent Bias (%) | -19 ± 45.7 | |
| SUVmax | Mean Error (SUV [g/mL]) | -7.6 ± 11.7 |
| Percent Bias (%) | -19 ± 71 | |
| SUVmean | Mean Error (SUV [g/mL]) | -2.5 ± 2.6 |
| Percent Bias (%) | -43 ± 46 |